Ameloblastoma: Clinical Trials

7 trials for Ameloblastoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 recruiting, 1 not yet recruiting, 1 unknown. 3 Phase 2, 2 Not applicable, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Completed 1, Not yet recruiting 1, Recruiting 1
Not applicable2Completed 1, Recruiting 1
Phase 32Not yet recruiting 1, Unknown 1

Follow Ameloblastoma: new trials by email Literature Review of Ameloblastoma trials Research Report on Ameloblastoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Neoadjuvant Therapy With Conservative Surgery vs. Up-front Conservative Surgery for BRAF V600E-Mutated Ameloblastoma
Dabrafenib and trametinib (combination) - Ameloblastoma
Phase 2 / Phase 3Not yet recruitingShanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University462025-03-012025-02-11
Virtual Lesion Segmentation and Mandibular Ameloblastoma Radiographic Safety Margin
Virtual lesion segmentation for mandibular ameloblastoma - Ameloblastoma
Not applicableRecruitingAlexandria University102025-01-012025-12-29
Exploration of Fenestration Decompression Combined With Dalafenib in the Treatment of BRAF Mutant Ameloblastoma
Dabrafenib - Ameloblastoma
Phase 3UnknownShandong University102024-03-012024-02-20
Effect of Tetracycline Socked Pack on Acceleration of Healing During Marsupialization
Tetracyclin - Ameloblastoma
Not applicableCompletedMinia University142024-02-102025-01-06
Clinical Study of Neoadjuvant Targeted Therapy for Ameloblastoma
Dabrafenib, Trametinib - Ameloblastoma, BRAF V600E Mutation Positive
Phase 2RecruitingShanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University122023-01-012024-10-22
Evaluation of the Expression and Prognostic Role of Tumor Stem Cell Marker SOX2 in Odontogenic Cysts and Tumors
Odontogenic Cysts, Odontogenic Tumors
CompletedMansoura University452022-04-012025-02-26
Dabrafenib and Trametinib in Treating Patients With BRAF Mutated Ameloblastoma
Dabrafenib, Trametinib - Ameloblastoma, BRAF Gene Mutation
Phase 2CompletedStanford University12017-07-172024-01-30

Narrower conditions

Adamantinoma (1)  ·  Dentigerous Cyst (1)  ·  Odontogenic Cysts (1)  ·  Odontogenic Tumors (1)

Broader conditions

Neoplasms (7)  ·  Neoplasms by Histologic Type (7)  ·  Odontogenic Tumors (6)  ·  Musculoskeletal Diseases (2)  ·  Bone Cysts (1)  ·  Bone Diseases (1)  ·  Bone Neoplasms (1)  ·  Cysts (1)  ·  Jaw Cysts (1)  ·  Jaw Diseases (1)  ·  Neoplasms by Site (1)  ·  Stomatognathic Diseases (1)

Interventions

dabrafenib (4)  ·  trametinib (3)  ·  Tetracycline (1)

Sponsors

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University (2)  ·  Alexandria University (1)  ·  Mansoura University (1)  ·  Minia University (1)  ·  Shandong University (1)  ·  Stanford University (1)

Countries

Egypt (3)  ·  China (1)  ·  United States (1)

Top investigators

Alexander Colevas (1)  ·  Qing Li (1)

Results publications

PMID 37966914, PMID 39274556, PMID 41176605